Imatinib mesylate and Quality of life decreased - from FDA reports


Summary

Quality of life decreased is reported only by a few people who take Imatinib Mesylate. We study 1,932 people who have side effects while taking Imatinib mesylate from FDA. Among them, 2 have Quality of life decreased. Find out below who they are, when they have Quality of life decreased and more.

What to expect?

If you take Imatinib mesylate and have Quality of life decreased, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Imatinib mesylate and have Quality of life decreased

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Dec, 13, 2017

1,932 people reported to have side effects when taking Imatinib mesylate.
Among them, 2 people (0.1%) have Quality of life decreased


Number of reports submitted per year:

Could Imatinib mesylate cause Quality of life decreased?

Gender of people who have Quality of life decreased when taking Imatinib mesylate *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Quality of life decreased when taking Imatinib mesylate *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 100 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Top conditions involved for these people *:

  • Chronic Myeloid Leukaemia (2 people, 100.00%)
  • Osteoporosis (1 person, 50.00%)

Top co-used drugs for these people *:

  • Dasatinib (1 person, 50.00%)
  • Boniva (1 person, 50.00%)
  • Alendronate Sodium (1 person, 50.00%)

Top other side effects for these people *:

  • Pain (1 person, 50.00%)
  • Laryngeal Oedema (1 person, 50.00%)
  • Fear Of Disease (1 person, 50.00%)
  • Diarrhea (1 person, 50.00%)
  • Broken Bone (1 person, 50.00%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

Do you have Quality of life decreased when taking Imatinib mesylate?

Expand the study to include all drugs with the same ingredients

Quality of life decreased and drugs with ingredients of imatinib mesylate.

Expand the study to include reports from both FDA and eHealthMe

Quality of life decreased and Imatinib mesylate from FDA and eHealthMe reports

Imatinib mesylate

Imatinib mesylate has active ingredients of imatinib mesylate. It is often used in chronic myelogenous leukemia (cml). (latest outcomes from Imatinib mesylate 1,962 users)

Quality of life decreased

Quality of life decreased has been reported by people with indigestion, abdominal distension, high blood cholesterol, paroxysmal nocturnal haemoglobinuria, osteoporosis (latest reports from 7,484 Quality of life decreased patients).

Browse all side effects of Imatinib mesylate

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Quality of life decreased

Quality of life decreased

Could your condition cause Quality of life decreased

Quality of life decreased

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Imatinib mesylate and have Quality of life decreased.

Questions to the study

More questions >

User reviews to the study

More reviews >